AYURVEDA

The All India Institute of Ayurveda launched several digital initiatives during KAUMARACON-2026 in New Delhi, in an announcement reported on 15 October 2026. The initiatives include an AYUSH Start-up Portal, the AyuDIVA innovation and venture acceleration facility, and digital platforms related to Ayurveda assessment and clinical practice. The development reflects efforts to strengthen digital infrastructure and research in traditional healthcare, although the launch itself does not establish the effectiveness of individual Ayurvedic treatments.

India's Ministry of AYUSH announced standard treatment guidelines covering dermatological disorders in Ayurveda, Siddha, Unani, and Homoeopathy, with Yoga also included. The guidelines address conditions such as psoriasis, dermatitis, vitiligo, urticaria, and fungal skin infections. The initiative aims to strengthen consistency in clinical practice, diagnostic approaches, treatment, follow-up, and patient safety. Publication of the guidelines does not independently prove the effectiveness of every traditional treatment.

India's Ministry of AYUSH announced standard treatment guidelines for managing dermatological disorders across Ayurveda, Siddha, Unani, and Homoeopathy, with Yoga also included. The announcement was reported by Akashvani News on 13 October 2026. The initiative aims to improve consistency in clinical practice and strengthen quality assurance across the participating systems. The publication of guidelines does not, by itself, establish the effectiveness of every traditional treatment for every skin condition.

For today's Ayurveda section, I could not verify a distinct new clinical trial, regulatory announcement or research finding published on 12 October. A responsible alternative is an educational article on the importance of safety monitoring for traditional herbal medicines, clearly labelled as health education rather than breaking research news.

A recent report examines how insurance coverage, hospitals and investment could support the next phase of growth in India's Ayush sector, including Ayurveda. The report also emphasizes the importance of evidence-backed treatment as services expand.

Prime Minister Narendra Modi addressed the 9th World Ayurveda Congress on October 8 and inaugurated three National AYUSH Institutes, with the new facilities expected to add around 500 hospital beds and increase student capacity.

A new report says Ayurveda and other Ayush systems are entering a new phase of expansion as insurance coverage, hospitals and private investment increase, while evidence-based treatment remains a key requirement.

A large multicentre clinical study reported that daily use of a standardized Ashwagandha root extract for 24 weeks was generally well tolerated, including no observed liver or kidney injury during the study period.

A large multicenter clinical study reported no evidence of treatment-related liver or kidney injury among participants receiving a standardized ashwagandha root extract for 24 weeks.